Chronic lymphoproliferative disorder of NK cells

WikiDoc Resources for Chronic lymphoproliferative disorder of NK cells
Articles
Most recent articles on Chronic lymphoproliferative disorder of NK cells Most cited articles on Chronic lymphoproliferative disorder of NK cells Review articles on Chronic lymphoproliferative disorder of NK cells Articles on Chronic lymphoproliferative disorder of NK cells in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Chronic lymphoproliferative disorder of NK cells Images of Chronic lymphoproliferative disorder of NK cells Photos of Chronic lymphoproliferative disorder of NK cells Podcasts & MP3s on Chronic lymphoproliferative disorder of NK cells Videos on Chronic lymphoproliferative disorder of NK cells
Evidence Based Medicine
Cochrane Collaboration on Chronic lymphoproliferative disorder of NK cells Bandolier on Chronic lymphoproliferative disorder of NK cells TRIP on Chronic lymphoproliferative disorder of NK cells
Clinical Trials
Ongoing Trials on Chronic lymphoproliferative disorder of NK cells at Clinical Trials.gov Trial results on Chronic lymphoproliferative disorder of NK cells Clinical Trials on Chronic lymphoproliferative disorder of NK cells at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Chronic lymphoproliferative disorder of NK cells NICE Guidance on Chronic lymphoproliferative disorder of NK cells NHS PRODIGY Guidance FDA on Chronic lymphoproliferative disorder of NK cells CDC on Chronic lymphoproliferative disorder of NK cells
Books
Books on Chronic lymphoproliferative disorder of NK cells
News
Chronic lymphoproliferative disorder of NK cells in the news Be alerted to news on Chronic lymphoproliferative disorder of NK cells News trends on Chronic lymphoproliferative disorder of NK cells
Commentary
Blogs on Chronic lymphoproliferative disorder of NK cells
Definitions
Definitions of Chronic lymphoproliferative disorder of NK cells
Patient Resources / Community
Patient resources on Chronic lymphoproliferative disorder of NK cells Discussion groups on Chronic lymphoproliferative disorder of NK cells Patient Handouts on Chronic lymphoproliferative disorder of NK cells Directions to Hospitals Treating Chronic lymphoproliferative disorder of NK cells Risk calculators and risk factors for Chronic lymphoproliferative disorder of NK cells
Healthcare Provider Resources
Symptoms of Chronic lymphoproliferative disorder of NK cells Causes & Risk Factors for Chronic lymphoproliferative disorder of NK cells Diagnostic studies for Chronic lymphoproliferative disorder of NK cells Treatment of Chronic lymphoproliferative disorder of NK cells
Continuing Medical Education (CME)
CME Programs on Chronic lymphoproliferative disorder of NK cells
International
Chronic lymphoproliferative disorder of NK cells en Espanol Chronic lymphoproliferative disorder of NK cells en Francais
Business
Chronic lymphoproliferative disorder of NK cells in the Marketplace Patents on Chronic lymphoproliferative disorder of NK cells
Experimental / Informatics
List of terms related to Chronic lymphoproliferative disorder of NK cells

Template:DiseaseDisorder infobox Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alberto Plate [2]

Synonyms and keywords: Chronic NK-cell lymphocytosis; chronic NK-Iarge granular lymphocyte (LGL) lymphoroliferative disorder; Nk-cell lineage granular lymphocyte proliferative disorder; Nk-cell LGL lymphocytosis; Indolent large granular NK-cell lymphoproliferative disorder.

Overview

The chronic Iymphoproliferative disorders of NK cells include a vast range of heterogenous diseases. These are characterized by NK cells >2x10^9/L in peripheral blood for more than 6 months without clear cause.

Classification

The Chronic lymphoproliferative disorder of NK cells (CLDNK) can be sub classified according to the variable expression of CD56, as follows:

• CD56 Positive
• CD56 Negative
• CD56 Partial

Given that CD16 is always present (although in variable amounts), it doesn't, therefor, allow us to further sub classify it. Classifying CLDNK according to CD56 allows us to predict clinical manifestations, such as:

• In a study, anemia and neutropenia showed to have higher incidence in CD56-Negative and CD56-Partial CLDNK patients.

File:Pathophysiology Table1 CLDNK.png

• In the same study, out of 6 patients with CLDNK who presented splenomegaly, 3 were CD56-Negative.

Pathophysiology

Chronic lymphoproliferative disorder of NK cells have been associated with other hematological tumors, vasculitis, splenectomy, neuropathy and autoimmune diseases.

Morphology

Circulating NK cells tend to be intermediate size with a round nucleus and condensed chromatin, with basofilix cytoplasm and azurophilic granules. The bone marrow biopsy, instead, show intrasinusoidal and interstitial infiltration of small cells with small and irregular nucleus and pale cytoplasm.

Immunophenotype

• Surface CD3 is negative, while cytoplasmic CD3 tends to be positive.
• CD16 positive
• Weak expression of CD56
• Cytotoxic markers: TIA-1, granzyme B and granzyme M positive.
• Diminished expression of CD2, CD7 and CD57.
• Aberrant expression of CD5 and CD8.
• Diminished CD161 expression.

Causes

Peripheral increased levels of NK cells have been associated with autoimmune diseases and viral infections, although no correlation has been found between those and a chronic lymphoproliferative disorder of NK cells

However, molecular studies have shown that lymphoproliferative disease of granular lymphocytes (LDGL) express CD16 and CD56, but no CD3. Furthermore, LDGL patients variably expressed NKp30, NKp44, and NKp46 RNA, but always expressed CD94 and NKG2A. Polymerase chain reaction (PCR) showed that lower levels of KIR antibodies were present on LDGL patients than in healthy patients. As well as a high level of activating receptors, NK-LDGL cells have potent cytolytic function. Therefor, NK-LDGL have a higher activating-to-inhibitory KIR ratio, which might induce inappropriate lysis or cytokine production, playing a role in the disease pathogenesis .

Epidemiology and Demographics

Affects predominantly adults (with an average of 60 years), with no distinguishable difference in gender and no racial or genetic predisposition.

Natural History, Complications and Prognosis

Most patients have an indolent clinical course for a long period of time. The disease might progress and develop as a cytopenia, recurrent infections and other comorbidities, in which case we'll be facing a worse prognosis.

In some cases, spontaneous and complete remission happens , although, some cases, might transform into anaggresive NK-cell disorder. Some factors have been associated with the malignant transformation, such as

• Morphologic factors: mature, medium-sized lymphocytes with sparse azurophil granules
• Surface receptors: CD2+, CD11+, CD16+ and CD3-.
• Karyotipic abnormalities: Trisomy 8.

Diagnosis

History and Symptoms

Generally patients are asymptomatic, although some present with diverse cytopenias, mainly anemia and neutropenia. Less frequently, patients may present with hepatomegaly, splenomegaly and cutaneous lessions.